Travere Therapeutics (TVTX) EBT Margin Growth (3y) (2017 - 2026)
Travere Therapeutics (TVTX) EBT Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn | 28,350.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28,350.00 |
| Dec 31, 2025 | 29,766.00 |
| Sep 30, 2025 | 36,319.00 |
| Jun 30, 2025 | 26,816.00 |
| Mar 31, 2025 | 29,855.00 |
| Dec 31, 2024 | -13,678.00 |
| Sep 30, 2024 | -3,500.00 |
| Jun 30, 2024 | -5,721.00 |
| Mar 31, 2024 | -21,518.00 |
| Dec 31, 2023 | 4,301.00 |
| Sep 30, 2023 | -19,649.00 |
| Jun 30, 2023 | -26,270.00 |
| Mar 31, 2023 | -27,434.00 |
| Dec 31, 2022 | -22,693.00 |
| Sep 30, 2022 | -21,549.00 |
| Jun 30, 2022 | -19,287.00 |
| Mar 31, 2022 | -24,640.00 |
| Dec 31, 2021 | 7,313.00 |
| Sep 30, 2021 | 8,073.00 |
| Jun 30, 2021 | -1,773.00 |